CHEMICALLY-MODIFIED DEXTRANS MODULATE EXPRESSION OF COLLAGEN PHENOTYPE BY CULTURED SMOOTH-MUSCLE CELLS IN RELATION TO THE DEGREE OF CARBOXYMETHYL, BENZYLAMIDE, AND SULFATION SUBSTITUTIONS
P. Mestries et al., CHEMICALLY-MODIFIED DEXTRANS MODULATE EXPRESSION OF COLLAGEN PHENOTYPE BY CULTURED SMOOTH-MUSCLE CELLS IN RELATION TO THE DEGREE OF CARBOXYMETHYL, BENZYLAMIDE, AND SULFATION SUBSTITUTIONS, Journal of biomedical materials research, 42(2), 1998, pp. 286-294
We developed regenerating agents (RGTAs) corresponding to polysacchari
des derived from dextran and containing defined amounts of carboxymeth
yl (CM), carboxymethyl sulfate (CMS), carboxymethyl benzylamine (CMB),
or carboxymethyl benzylamide sulfate (CMBS) groups with varying degre
es of substitution. These compounds mimicked some effects of heparin o
n smooth muscle cell (SMC) proliferation and promoted in vivo tissue r
emodeling. We demonstrated that only RGTAs containing both CM and sulf
ate groups decreased SMC proliferation, in correlation with increased
sulfation level. This effect was amplified by the presence of benzylam
ide. Independent of this activity on cell proliferation (i.e., with po
stconfluent cells), RGTAs modulated collagen biosynthesis by SMCs. On
the one hand, CMBS more than CMS RGTAs induced a decrease of collagen
Ill synthesis at the level of mRNA steady state and protein production
. On the other hand, CMS to a greater extent than CMBS RGTAs increased
both collagen V mRNA and protein production. In addition, only benzyl
amide-containing RGTAs increased accumulation of collagen I and III in
the cell lever. In conclusion, RGTA bioactivities required the presen
ce of CM functions, increased with the sulfation level, and varied wit
h benzylamide substitution. RGTAs that modulate cell proliferation and
collagen biosynthesis by differential mechanisms may represent potent
ial antifibrotic agents. (C) 1998 John Wiley & Sons, Inc.